Skip to main content

Table 1

From: P025. Two-year follow-up with OnabotulinumtoxinA for chronic migraine: a real life evaluation of 113 patients

Time in months

Headache Days

% of Reduction vs Baseline

Baseline

24.1 (22.1 - 26.3)

 

3

16.4 (14.8 - 18.1)

32

6

11.1 (9.7 - 12.7)

54

9

7.5 (6.3 - 9.1)

69

12

5.1 (4.0 - 6.5)

79

15

3.5 (2.6 - 4.7)

85.5

18

2.4 (1.7 - 3.3)

90

21

1.6 (1.1 - 2.4)

94.4

24

1.1 (0.7 - 1.7)

95.4